To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 606.00 |
Bid | 604.00 |
Ask | 612.00 |
Change | 0.00 (0.00%) |
Volume | 2,744 |
Open | 606.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 606.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.75m |
Market Capitalisation | £228.78m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 13 |
---|---|
Vol. Sold | 1,486 |
Sold Value | £9.02k |
Vol. Bought | 1,258 |
Bought Value | £7.68k |
PE Ratio | 36.09291 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.653% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 11:36:38 | 610.24 | 870 | Buy* | 604.00 | 612.00 | 5,309 | O Ordinary |
26-Apr-24 | 11:20:32 | 607.3333 | 1,400 | Sell* | 604.00 | 612.00 | 8,503 | O Ordinary |
26-Apr-24 | 11:09:34 | 610.00 | 93 | Buy* | 604.00 | 612.00 | 567.30 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 11:09:34 | 604.00 | 76 | Sell* | 604.00 | 612.00 | 459.04 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 11:09:34 | 610.00 | 2 | Buy* | 604.00 | 612.00 | 12.20 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 10:47:09 | 610.232 | 84 | Buy* | 604.00 | 612.00 | 512.59 | O Ordinary |
26-Apr-24 | 10:06:07 | 607.3333 | 10 | Sell* | 604.00 | 612.00 | 60.73 | O Ordinary |
26-Apr-24 | 09:53:29 | 610.24 | 6 | Buy* | 604.00 | 612.00 | 36.61 | O Ordinary |
26-Apr-24 | 09:20:29 | 610.24 | 32 | Buy* | 604.00 | 612.00 | 195.28 | O Ordinary |
26-Apr-24 | 08:59:21 | 610.24 | 161 | Buy* | 604.00 | 612.00 | 982.49 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |